Skip to main content
Premium Trial:

Request an Annual Quote

AxCell and Compaq Form Database Partnership



RINCETON, NJ--AxCell Biosciences, a wholly owned subsidiary of Cytogen, has entered into a partnership with Compaq to develop a database software package that the companies said will help select promising drug targets from protein pathway data generated by AxCell. The program will be facilitated by Compaq’s Alpha, high-performance, 64-bit systems to deliver speed and scalability advantages.

Using high-throughput methods, with InforMax, AxCell said it is creating what it calls an Inter-Functional Proteomic Database to identify protein interactions and novel drug targets, which are also potentially useful in determining which compounds are likely to have the fewest side effects.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.